Cancer Genetics Enters Into In-Network Provider Agreements to Expand the Availability of Genetic Testing

Life Science Investing News

Cancer Genetics, Inc. (Nasdaq:CGIX) has entered into in-network provider agreements with Blue Cross Blue Shield of North Carolina, Blue Cross Blue Shield Nebraska, and WellMark, Inc.

Cancer Genetics, Inc. (Nasdaq:CGIX) has entered into in-network provider agreements with Blue Cross Blue Shield of North Carolina, Blue Cross Blue Shield Nebraska, and WellMark, Inc.

According to the press release:

Each of these healthcare networks have served their respective communities for over seventy-five years and cover a combined customer base of over 6.7 million individuals. The agreement with CGI will allow members of these networks access to CGI’s cancer diagnostic services.

Blue Cross Blue Shield of North Carolina was founded in 1933 as the Hospital Care Association of Durham by local business man George Watts Hill and Dr. W.C. Davison, Dean of Duke University School of Medicine. Today, BCBS of North Carolina serves over 3.9 million customers and strives to deliver on its mission to improve the health and well being of its customers and communities.
With a focus on its mission to provide health and wellness solutions people value most, today Blue Cross Blue Shield of Nebraska serves over 700,000 people. The company is committed to providing quality service and stays true to its core values of customer focus, collaboration, respect, innovation, trust and respect.
Headquartered in Des Moines, Iowa, Wellmark, Inc., has provided access to quality, affordable healthcare since 1939 to members at every stage of their lives. The Wellmark network covers 1.8 million Iowans and 300,000 South Dakotans. Wellmark partnered with over 2,000 primary care physicians and developed a network of innovative wellness programs for its members as part of its focus on providing coordinated, high-quality care. Wellmark members who meet coverage and medical necessity guidelines will be able to access CGIs comprehensive menu of oncology diagnostic tests through their network physician.

Click here to read the full press release.

 

The Conversation (0)
×